Molecular Docking of Thaflavine from Camellia sinensis in Inhibiting B-Cell Lymphoma Through BCl2 Apoptosis Regulator: An In Silico Study

R Zainul, R Verawati, H Satriawan… - Pharmacognosy …, 2023 - phcogj.com
This study aims to analyze the potential of Thaflavine, a compound found in green tea
(Camellia sinensis), as an inhibitor in inhibiting B-cell lymphoma through its interaction with …

In Silico Computational Studies of Bioactive Secondary Metabolites from Wedelia trilobata against Anti-Apoptotic B-Cell Lymphoma-2 (Bcl-2) Protein Associated with …

HG Gowtham, F Ahmed, S Anandan, CS Shivakumara… - Molecules, 2023 - mdpi.com
In the present study, the binding affinity of 52 bioactive secondary metabolites from Wedelia
trilobata towards the anti-apoptotic B-cell lymphoma-2 (Bcl-2) protein (PDB: 2W3L) structure …

[PDF][PDF] A Structure-Based Design Approach to Catharanthus roseus Phytoconstituents as Potential Inhibitors of B-Cell Lymphoma 6 Protein

S Attar, S Bhor - Int. J. Bioinf. Comput. Biol, 2023 - academia.edu
Objectives: Lymphoma is a cancerous disease. It develops into millions of people
worldwide. Identify the naturally active compounds from Catharanthus roseus, they have …

In Silico Target Identification and Molecular Docking Studies of Natural Cytotoxic Compound Borivilianoside H

SD Gupta, P Kohli - Current Biotechnology, 2019 - ingentaconnect.com
Background: Borivilianoside H is a naturally occurring anti-cancer compound with known
cytotoxicity against human colorectal cancer cell line (HCT-116) and human …

[HTML][HTML] Molecular docking studies of phytocompounds from Aloe vera (L.) Burm. F. having anticancer property, against an antiapoptotic Bcl-2 Protein

DN Nair, S Padmavathy - Biosciences Biotechnology Research …, 2017 - biotech-asia.org
B-cell lymphocyte-2 (Bcl-2) is an antiapoptotic protein, which is an important member of Bcl-
2 family. The current study involves molecular docking of six antineoplastic phytocompounds …

Molecular docking studies of Brucein D as a potential inhibitor of the Bcl-2 anti-apoptotic protein

PI Nandana, H Rasyid, I Yustisia, L Hakim - Bali Medical …, 2023 - scholar.unair.ac.id
Background: Brucein D (BrD), a quassinoid isolated from Brucea javanica fruit, reportedly
demonstrates anti-tumor activity. Bcl-2 is an anti-apoptotic protein that inhibits apoptosis and …

Pharmacoinformatics based screening of combined synthetic and natural compounds to identify novel and in silico potential Bcl-2 inhibitors

S Krishna, TPK Murthy, G Divyashri, M Murahari… - Journal of Molecular …, 2022 - Elsevier
The apoptotic balance of the cell is governed by Bcl-2 protein family. Increased expression
of pro-survival members of Bcl-2 family is indicative of cell death evasion and cancer …

In silico prediction of Anti-apoptotic BCL-2 proteins Modulation by Afzelin in MDA-MB-231 Breast cancer cell

E Rachmi, BB Purnomo, AT Endharti… - Research Journal of …, 2020 - indianjournals.com
Triple-negative breast cancer (TNBC) has aggressive characteristics, and lower overall-and
disease-free survival compared to other breast cancer subtypes. TNBC tends to be apoptotic …

Molecular docking study of naturally derived flavonoids with antiapoptotic BCL-2 and BCL-XL proteins toward ovarian cancer treatment

MF Abd Ghani, R Othman, N Nordin - Journal of Pharmacy and …, 2020 - journals.lww.com
MATERIALS AND METHODS All the molecular docking functions in this study were
performed using AutoDock Vina.[11] This docking software has been reported to provide …

[PDF][PDF] In-silico screening of flavonoids targeted for death receptors in cancer by using Hex molecular docking

VJ Vishnuvarthan, KS Lakshmi… - Journal of Young …, 2017 - jyoungpharm.org
Objective: Docking is one of the major tools in the drug development process, here we have
selected certain flavonoid molecules such as Formononetin, Tangeritin, Myricetin and …